The potential for carotenoids to modulate chronic disease risk is curr
ently under investigation, and renewed interest has been placed on ach
ieving a better understanding of the mechanisms of action of carotenoi
ds in biologic systems. Available data currently show that the antioxi
dant activity of these compounds may shift into prooxidant activity, d
epending on the redox potential of the carotenoid molecules as well as
on the biologic environment in which they act The prooxidant potency
of these compounds is determined by several factors, including oxygen
tension, carotenoid concentration, and interactions with other antioxi
dants. Prooxidant activity can induce either beneficial or harmful res
ults in biologic systems and influence the development of human chroni
c diseases.